These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28190749)

  • 1. Role of radical prostatectomy in metastatic prostate cancer: A review.
    Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
    Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
    Bayne CE; Williams SB; Cooperberg MR; Gleave ME; Graefen M; Montorsi F; Novara G; Smaldone MC; Sooriakumaran P; Wiklund PN; Chapin BF
    Eur Urol; 2016 May; 69(5):775-87. PubMed ID: 26003223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
    Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
    World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of cytoreductive prostatectomy in patients with metastatic disease.
    Jaber Y; Reichard CA; Chapin BF
    Transl Androl Urol; 2018 Sep; 7(Suppl 4):S505-S513. PubMed ID: 30363448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of surgery in oligometastatic prostate cancer.
    Jenjitranant P; Touijer KA
    Prostate Int; 2019 Dec; 7(4):125-130. PubMed ID: 31970136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive prostatectomy: what is the evidence? A systematic review.
    Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
    Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy in oligometastatic prostate cancer.
    Mandel P; Steuber T; Graefen M
    Curr Opin Urol; 2017 Nov; 27(6):572-579. PubMed ID: 28825924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive radical prostatectomy versus systemic therapy and radiation therapy in metastatic prostate cancer: A systematic review and meta-analysis.
    Shemshaki H; Al-Mamari SA; Geelani IA; Kumar S
    Urologia; 2022 Feb; 89(1):16-30. PubMed ID: 34355602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive prostatectomy: evidence in support of a new surgical paradigm (Review).
    Faiena I; Singer EA; Pumill C; Kim IY
    Int J Oncol; 2014 Dec; 45(6):2193-8. PubMed ID: 25340386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
    Heidenreich A; Pfister D; Porres D
    J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis.
    Wang Y; Qin Z; Wang Y; Chen C; Wang Y; Meng X; Song N
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Therapy Improves Survival in Metastatic Prostate Cancer.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
    Heidenreich A; Pfister D
    Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
    Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
    BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer.
    Yanagisawa T; Rajwa P; Kawada T; Bekku K; Laukhtina E; Deimling MV; Majdoub M; Chlosta M; Karakiewicz PI; Heidenreich A; Kimura T; Shariat SF
    Curr Oncol; 2023 Feb; 30(2):2194-2216. PubMed ID: 36826131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of local disease in metastatic prostate cancer.].
    Gaya JM; Huguet J; Breda A; Palou J
    Arch Esp Urol; 2018 Mar; 71(3):288-297. PubMed ID: 29633950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Might definitive local therapy of the primary tumor improve the survival benefits of metastatic prostate cancer?-evidence from a meta-analysis.
    Xiao M; Cong R; Zhang Q; Xiang W; Xiao H
    Ann Palliat Med; 2020 May; 9(3):648-660. PubMed ID: 32312070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytoreductive radical prostatectomy in metastatic prostate cancer.
    Vladimír Š; Zuzana S; Hana Š
    Klin Onkol; 2022; 35(1):55-62. PubMed ID: 35236082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer.
    Ristau BT; Cahn D; Uzzo RG; Chapin BF; Smaldone MC
    Future Oncol; 2016 Mar; 12(5):687-99. PubMed ID: 26839141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.